{"title":"为什么激素避孕和更年期激素治疗对乳腺癌风险的影响如此之小?","authors":"John A. Eden","doi":"10.1111/ajo.13825","DOIUrl":null,"url":null,"abstract":"Oestrogen is considered by many to be a major cause of breast cancer, and yet hormonal contraception and menopausal hormonal therapy have a paradoxically small effect on breast cancer risk. Also, in the oestrogen‐only arm of the Women's Health Initiative, subjects given oestrogen had a reduced risk of breast cancer compared to controls. Initiation of breast cancer likely begins early in life, in the long‐lived ER<jats:sup>−</jats:sup>PR<jats:sup>−</jats:sup> breast stem cell. The main mitogen of ER<jats:sup>+</jats:sup>PR<jats:sup>+</jats:sup> breast cancers is oestrogen derived from local breast fat and the tumour itself, rather than circulating oestrogens. Progesterone is relatively breast neutral, but progestins in the laboratory have been shown to expand malignant breast stem cell number.","PeriodicalId":8599,"journal":{"name":"Australian and New Zealand Journal of Obstetrics and Gynaecology","volume":"88 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk?\",\"authors\":\"John A. Eden\",\"doi\":\"10.1111/ajo.13825\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Oestrogen is considered by many to be a major cause of breast cancer, and yet hormonal contraception and menopausal hormonal therapy have a paradoxically small effect on breast cancer risk. Also, in the oestrogen‐only arm of the Women's Health Initiative, subjects given oestrogen had a reduced risk of breast cancer compared to controls. Initiation of breast cancer likely begins early in life, in the long‐lived ER<jats:sup>−</jats:sup>PR<jats:sup>−</jats:sup> breast stem cell. The main mitogen of ER<jats:sup>+</jats:sup>PR<jats:sup>+</jats:sup> breast cancers is oestrogen derived from local breast fat and the tumour itself, rather than circulating oestrogens. Progesterone is relatively breast neutral, but progestins in the laboratory have been shown to expand malignant breast stem cell number.\",\"PeriodicalId\":8599,\"journal\":{\"name\":\"Australian and New Zealand Journal of Obstetrics and Gynaecology\",\"volume\":\"88 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Australian and New Zealand Journal of Obstetrics and Gynaecology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/ajo.13825\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian and New Zealand Journal of Obstetrics and Gynaecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ajo.13825","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
雌激素被许多人认为是导致乳腺癌的主要原因,然而激素避孕和更年期激素治疗对乳腺癌风险的影响却很小。此外,在 "妇女健康倡议"(Women's Health Initiative)的纯雌激素治疗组中,与对照组相比,服用雌激素的受试者患乳腺癌的风险更低。乳腺癌的发病可能始于生命早期,即寿命较长的ER-PR-乳腺干细胞。ER+PR+乳腺癌的主要有丝分裂原是来自局部乳房脂肪和肿瘤本身的雌激素,而不是循环中的雌激素。孕激素对乳腺癌的影响相对较小,但实验室研究表明,孕激素会增加恶性乳腺干细胞的数量。
Why does hormonal contraception and menopausal hormonal treatment have such a small effect on breast cancer risk?
Oestrogen is considered by many to be a major cause of breast cancer, and yet hormonal contraception and menopausal hormonal therapy have a paradoxically small effect on breast cancer risk. Also, in the oestrogen‐only arm of the Women's Health Initiative, subjects given oestrogen had a reduced risk of breast cancer compared to controls. Initiation of breast cancer likely begins early in life, in the long‐lived ER−PR− breast stem cell. The main mitogen of ER+PR+ breast cancers is oestrogen derived from local breast fat and the tumour itself, rather than circulating oestrogens. Progesterone is relatively breast neutral, but progestins in the laboratory have been shown to expand malignant breast stem cell number.